DEXTROSE 5% AND SODIUM CHLORIDE 0.45% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dextrose 5% And Sodium Chloride 0.45%, and when can generic versions of Dextrose 5% And Sodium Chloride 0.45% launch?
Dextrose 5% And Sodium Chloride 0.45% is a drug marketed by Fresenius Kabi Usa, Abbott, B Braun, Icu Medical Inc, and Miles. and is included in six NDAs.
The generic ingredient in DEXTROSE 5% AND SODIUM CHLORIDE 0.45% is dextrose; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXTROSE 5% AND SODIUM CHLORIDE 0.45%?
- What are the global sales for DEXTROSE 5% AND SODIUM CHLORIDE 0.45%?
- What is Average Wholesale Price for DEXTROSE 5% AND SODIUM CHLORIDE 0.45%?
Summary for DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 3 |
DailyMed Link: | DEXTROSE 5% AND SODIUM CHLORIDE 0.45% at DailyMed |
Pharmacology for DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
Drug Class | Osmotic Laxative |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |